We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Release good news to get away yet another cheap placing, they are so bloody obvious, one positive that they sold Wyld shares at around 11sek and now buying them all back at around 2.5sek but hands up who is royally fed up with this lot
Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, announces that it has raised £420,000, before expenses, through a placing of 17,500,000 new ordinary shares ("Ordinary Shares") of 0.02p each in the Company (the "Placing Shares") at a price of 2.4 pence per new Ordinary Share (the "Issue Price") (the "Placing"). The Placing is conditional upon the Placing Shares being admitted to trading on AIM ("Admission").
The Placing Shares will represent approximately 4.1 per cent. of the Company's enlarged issued share capital following the Placing. The Issue Price represents a discount of approximately 30.4 per cent. to the mid-market closing price of 3.45 pence per Ordinary Share on 11 April 2024, being the latest practicable business day prior to the publication of this announcement.
The net proceeds of the Placing will be used to provide the Company with funds to invest in Wyld Networks, through the exercise of warrants held by the Company, and to invest further in one or more of Tern's portfolio companies and for general corporate purposes. Further announcements will be made by the Company in due course as appropriate.
Comprehensive Surgical VR Training is Powering Competence and Growth in Endovascular and Robotics
$
Home
$
Company Updates
$
Comprehensive Surgical VR Training is Powering Competence and Growth in Endovascular and Robotics
Virtual Reality training has emerged as a pivotal tool in the evolution of surgical training.
Published April 9, 2024
Author: Dr. Caitlin Houghton, Assistant Professor of Surgery at Keck Medicine of USC
Immersive VR offers streamlined training solutions that remove dependence on more traditional training methods, reducing the reliance on expensive cadaver and wet labs in favor of more agile and adaptive VR offerings.
Surgical robotics and training expert Dr. Caitlin Houghton (Keck Medicine of USC) identifies some of the key advantages of VR simulation utilization, including improved confidence, competence, and increased access to real-time feedback and assessment. Getting students and trainers onboard to adopt and deliver new techniques and technologies is easier than ever, with the ability to deploy VR simulations at scale and at any location. This allows for risk-free practice outside the confines of the classroom or operating room.
No longer are surgical students limited to education by one expert, specialist, or surgeon. VR is the vehicle for endless interactions with surgeons across specialties.
1790006013 1
“We have to think about sustainability and growth, instead of just adoption…you need a platform that’s going to continually change with you, continually let new learners be brought into the system… whether they’re nursing staff or new surgeons. Adoption seems finite. You might not invest in adoption, but you would invest in growth and sustainability.”
Dr. Caitlin Houghton, Assistant Professor of Surgery at Keck Medicine of USC
Emerging tech companies should prioritize investing in VR training modalities to accelerate the adoption of these platforms to grow surgical skills at an accelerated pace. VR platforms provide a common ground for collaboration across medical specialties, time zones, trainers, and students alike, all with the goal of improving patient care and outcomes worldwide.
Thanks for that advise Camkite
Is there anything to be seen in the fundamentals published on this site .
Other site just have n/a against price to earnings on these AIM shares .
Yahoo has Price/book (mrq) 0.62 mrq = Most-recent quarter
Shares in Issue 409.68m
Market Cap. £14.13m
Market Size 50,000
PE Ratio -1.181507
Earnings -2.92
Dividend 0.00
Yield 0.00%
Wouldn’t pay much attention to stuff like that on penny stocks. It’s the drivers - news, herd mentality, trends, charts like that on fairly illiquid pennies don’t mean much.
Looking pretty strong atm… one rns from the mgmt and they can soon dampen everyone’s optimism lol hopefully not but I wouldn’t be surprised, 12 years and completely useless is about the size of it.
Noticed this rising from the dip back to 2.2p on 3rd April 2024.
Would of been a great top up.
Steady rise to today's 3.6p 8 days on.
Up 7.46% today spread 5.7% 60% gain over the 8 days .
Share had fallen back to 1.7p by 20th March.
These guys not so sure what the tea leaves are saying at only 8%
https://www.barchart.com/stocks/quotes/TERN.LN/opinion
Overall Average:
8% SELL
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
You are misleading people as usual, nothing to do with Talking Medicine or Tern, no mention at all.
Prof David Clifton, puts forward the suggestion whose team at Oxford’s AI for Healthcare lab
Drug-gpt by TM
Will be used & is needed
as a standard , by every single GP in UK and is far superior that chat-gpt who he calls just a bot...
https://www.theguardian.com/science/2024/mar/31/druggpt-new-ai-tool-could-help-doctors-prescribe-medicine-in-england
Maybe so, but don’t you think he could very likely be correct?
Wyld Networks
@WyldNetworks
·
2h
We are excited to share our latest Wyld Connect and Wyld Fusion updates with the #LoRaWAN ecosystem in the marketplace at #LoRaWANLive Munich. We look forward to seeing you this June.
Register NOW to join us:
https://bit.ly/LoRaWANLive-Munich
AI magazine recommending Tern
X twitter
The Best AI
@TheBestAI_
Exploring Cutting-Edge Technology: Tern's Talking Medicines Kicks off 2024 Triumphan
Tech investors may want to turn their gaze towards the 'Internet of Things' investor, Tern, as it holds a promising 23.8% equity share in Talking Medicines. As of the first fiscal quarter of 2024, Talking Medicines has witnessed record-breaking revenue bookings and substantial advancements in its groundbreaking Drug-GPT platform.
Tern has 4 hungry dogs to feed, placing on the way as all this ramptastic nonsense signifies!
Always a danger when they release good news, they usually only release bad news and ignore the good stuff
There is no fundraise anytime soon
This sort of web page needed for various events like an IPO, are we heading down that road?
https://talkingmedicines.com/compliance-hub/
Probably the split second before you invested lol
Fingers crossed, they don’t raise into the rise, going off many years of previous performance, odds are slim.
LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery
$
Home
$
Events & Webinars
$
On Demand
$
LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery
ON DEMAND
LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery
Speaking at LSI USA, Richard Vincent shares how FundamentalVR is removing friction and shortening the learning curve for medical devices and procedures by developing immersive VR solutions that deliver Competency @ Scale.
“The key challenge with the move to digital surgery is really about the skills transfer… I’m talking about tenured surgeons, their teams, their nursing, their tech, who need to acquire new skills around the digital surgery space…And that’s where FundamentalVR comes in – we get into that space and virtualize it.”
Richard Vincent, CEO and Co-Founder of FundamentalVR
https://fundamentalsurgery.com/lsi-usa-2024-the-adoption-of-immersive-vr-to-drive-digital-surgery/
Sounds like TM is ready to attract more funds from other investors where TERN cannot participate other than reduce its % holdings!
I see toothless Tom Win is at it again. He’s a weasel.
No numbers given for this or any previous quarter.
No indication if revenue was above or below revenue growth projections made byTM.
No indication of gross margins.
Cant remember the last time i felt this confident about Terns potential
Blue day but no numbers will make any increase restrained but target was £3m, with them ahead of expectations, new target could well be alot higher, looks like TM are on fire, first RNS in a long time to get me looking forward to trading at 8am
Great news but would be good to see some numbers, o don’t think they were producing any revenue of note befire?